Berry Genomics, a Chinese genetic testing firm backed by Qiming Venture Partners and Legend Capital, is seeking to list in the A-share market via a reverse merger with Shenzhen-listed Chengdu Tianxing Instrument & Meter, according to a disclosure filing (in Chinese). The Chengdu-based auto parts maker plan to acquire 100% of Berry Genomics through an […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.